Sort
39,280 grants matching “leukemia”
High throughput CAR-T potency assay based on functional and transcriptional measurements on single cell co-cultures
$908,687Benjamin Biron Yellen · Celldom, Inc. · R44 · FY2025 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$908,642Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Towards targeting the lymphoma microenvironment
$908,577Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Regulated proteolysis in developmental signaling
$908,469Mark E Fortini · Basic Sciences · Z01 · FY2007 · CA
CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE
$908,401University Of Chicago · U10 · FY2001 · CA
Targeted Therapy for Leukemia
$908,348John C Byrd · Ohio State University · R35 · FY2018 · CA
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$907,829Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Mechanisms of Cellular Transformation by HTLV-1
$907,824Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA
$907,703The Children'S Hospital Of Philadelphia · · FY2025 · Defense Health Agency
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$907,233Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Activation and Silencing of Gene Expression during Hematopoiesis--OLD
$906,777Mark T Groudine · Fred Hutchinson Cancer Research Center · R01 · FY2010 · HL
Rochester Network Lead Academic Participating Site
$906,281Paul M Barr · University Of Rochester · UG1 · FY2021 · CA
Physical Activity to Modify Sequelae and QOL in Childhood ALL: A Nursing Trial
$906,191Cheryl Lorane Cox · St. Jude Children'S Research Hospital · R01 · FY2010 · CA
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta
$905,570Kyle Russell Bonneau · Cellecta, Inc. · R44 · FY2012 · CA
Activation and Silencing of Gene Expression during Hematopoiesis--OLD
$905,478Mark T Groudine · Fred Hutchinson Cancer Research Center · R01 · FY2011 · HL
Activation and Silencing of Gene Expression during Hematopoiesis--OLD
$905,478Mark T Groudine · Fred Hutchinson Cancer Research Center · R01 · FY2012 · HL
Epigenetic Regulation of Hematopoietic Stem Cells
$905,402Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$905,230Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Identifying non-coding RNAs for early detection and prevention of lung cancer
$905,221Carlo M Croce · Ohio State University · U01 · FY2015 · CA
Novel signaling molecules regulating platelet activation
$905,104Satya P. Kunapuli · Temple Univ Of The Commonwealth · R35 · FY2025 · HL
Mechanisms of Cellular Transformation by HTLV-1
$904,857Kuan-Teh Jeang · Niaid Extramural Activities · Z01 · FY2007 · AI
Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells
$904,588Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
A Training Program in Molecular Hematology
$904,346Robert I Handin · Harvard Medical School · T32 · FY2008 · HL
Hematopathology Diagnosis
$904,289Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Clinical Development of Novel Drugs for Children with Refractory Cancers
$903,024Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA